Henry J. Kaiser Family Foundation • International News

Indian Health Officials Welcome Patent Rejections of HIV/AIDS Drugs

September 9, 2009

Reuters examines Indian health officials' positive reaction to the recent decision by the country's patent office to reject patent applications on two "life-saving HIV/AIDS drugs." The decision, they say, will help to ensure patients living with HIV/AIDS have access to generic HIV/AIDS drugs, which cost a fraction of the price of patented drugs. The drug companies did not comment about their patents' rejection for the story (Majumdar, 9/9).

Back to other news for September 2009

Search the Newsroom archive

This information was reprinted from kff.org with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.

My Health Tracker

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

World AIDS Day 2009: Home

HIV Antiretrovirals in Development: An Update From ICAAC 2009

Back From the Brink: A Blog Entry by Thomas DeLorenzo

More >>

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.